Search

9850 results for: ‘global learning outcomes’

  • French Language (Beginners)

    Module code: FR1040 Our language modules for Beginners are intensive language courses which bring you up to the A2 level of the Common European Framework for Languages (CEFR) in a year.

  • French Language (Beginners)

    Module code: FR1020+FR1021 Our language modules for Beginners are intensive language courses which bring you up to the A2 level of the Common European Framework for Languages (CEFR) in a year.

  • French Language (Beginners)

    Module code: FR1040 Our language modules for Beginners are intensive language courses which bring you up to the A2 level of the Common European Framework for Languages (CEFR) in a year.

  • Applications

    See step-by-step guidance on how to apply for one of our postgraduate courses: choosing a course, gathering your documentation and completing our application form.

  • Available PhD projects

    Browse PhD projects and the supervisors who run them in the Department of Genetics and Genome Biology at the University of Leicester.

  • Latest award for Centre for Medicine recognises efforts to promote positive change

    Our award-winning Centre for Medicine continues to be recognised for its ground breaking design and contribution to promoting sustainability, with its latest success being a win in the Global Good Awards UK.

  • Leicester geneticist involved in internet for DNA

    Scientists at the University of Leicester are playing a central role in the development of what is being described as ‘an internet for DNA’.

  • Opportunities open up in South Korea for students and researchers

    We have signed a new agreement with a major university in South Korea to send students to South East Asia as part of their degree programme.

  • Leicester Tuberculosis Research Group

    Discover more about the Leicester Tuberculosis Research Group (LTBRG) at the University of Leicester.

  • Mayer IgA Nephropathy Research Group

    Leicester’s Mayer IgAN Research Group leads global efforts to treat chronic kidney disease, backed by major funding and pioneering clinical breakthroughs.

Back to top
MENU